CJC-no DAC / Ipamorelin Blend – 5mg/5mg (10 vials/kit)

CJC-1295 no DAC Ipamorelin Blend – 5mg/5mg For Research Use Only
Discover the CJC-no DAC Ipamorelin blend, a powerful research peptide combination designed for scientific investigation into growth hormone pathways and cellular signaling mechanisms. This synergistic peptide blend combines two highly studied growth hormone releasing peptides to provide researchers with a comprehensive tool for exploring GH-related biological processes.

What is CJC-1295 no DAC Ipamorelin Blend?

The CJC-no DAC Ipamorelin blend represents an innovative combination of two pharmaceutical-grade research peptides. CJC-1295 without DAC, also known as Modified GRF 1-29, is a growth hormone releasing hormone analog that has been extensively studied for its ability to stimulate pulsatile growth hormone release. Ipamorelin is a selective growth hormone secretagogue receptor agonist recognized for its specificity and minimal side effect profile in research settings.

This research peptide blend is manufactured at a verified purity of 99% or higher and is presented in sterile 10mg vials. Each vial contains 5mg of CJC-no DAC peptide and 5mg of Ipamorelin peptide in lyophilized powder form, ensuring optimal stability and research applicability. The combination provides researchers with a synergistic approach to investigating growth hormone pathways and related physiological mechanisms.

Key Product Specifications:

Unit Size: 10mg per vial (5mg CJC + 5mg Ipamorelin)
Purity: ≥99%
Form: Lyophilized powder
Storage: Store in a dry, cool environment
Peptide Type: Growth hormone releasing peptide blend
Application: Laboratory and research use only

Research Applications and Scientific Interest

The CJC Ipamorelin blend has garnered significant attention in peptide research communities for its potential applications in studying growth hormone pathways. This synergistic peptide combination allows researchers to investigate the coordinated effects of multiple GH releasing mechanisms, providing insights into complex hormonal regulation and cellular signaling cascades.

Research into this pharmaceutical-grade CJC peptide blend focuses on understanding how growth hormone releasing peptides interact with cellular receptors and influence downstream biological processes. The Ipamorelin peptide component contributes selectivity, while the CJC peptide provides sustained signaling characteristics, making this blend particularly valuable for longitudinal research studies.

Why Choose This Research Peptide Blend?

Our CJC-no DAC Ipamorelin blend is manufactured to the highest pharmaceutical standards, ensuring consistent quality and purity for research applications. The synergistic peptide formulation provides researchers with a reliable tool for investigating growth hormone biology, cellular metabolism, and related physiological systems. Each batch undergoes rigorous quality control testing to verify purity and composition.

Important Research Notice

This CJC Ipamorelin blend is intended strictly for professional laboratory testing and research environments. It is not approved for human or animal consumption and should only be handled by qualified researchers in appropriate laboratory settings. All research should be conducted in compliance with institutional guidelines and ethical standards for peptide research.

Order your pharmaceutical-grade CJC-no DAC Ipamorelin blend today and advance your research into growth hormone releasing peptides and their biological mechanisms.

 

Storage and Handling Guidelines

Proper storage of CJC-1295 no DAC Ipamorelin blend is essential to maintain peptide integrity and research efficacy. Upon receipt, store vials at 2-8°C in a refrigerated environment away from direct light exposure. For extended storage periods exceeding 90 days, maintain vials at -20°C in a freezer to preserve the molecular structure of both CJC-1295 and Ipamorelin components. Once reconstituted, the peptide solution should be stored refrigerated and used within 30 days for optimal research outcomes.

Reconstitution Protocol for Research

When preparing the CJC-1295 no DAC Ipamorelin blend for laboratory applications, use only pharmaceutical-grade bacteriostatic water or appropriate sterile buffer solutions. Allow the lyophilized powder to equilibrate to room temperature before adding solvent to prevent thermal stress on the peptide structure. Introduce the reconstitution fluid slowly along the vial wall, avoiding direct contact with the lyophilized cake. Gently swirl the vial in a circular motion rather than vigorous shaking to facilitate complete dissolution while minimizing peptide degradation and maintaining the biological activity of both growth hormone releasing components.